STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 3] Vyome Holdings, Inc Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

John M. Tincoff III filed an initial Form 3 reporting his relationship to Vyome Holdings, Inc. (ticker shown in the filing as HIND) as a Director. The event date is 08/15/2025. The filing states no securities are beneficially owned by the reporting person. The form is signed and dated 09/18/2025.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A director filed an initial ownership statement reporting no beneficial holdings, a routine governance disclosure.

The filing shows John M. Tincoff III as a director of Vyome Holdings, Inc. and contains an initial statement of beneficial ownership with an explicit declaration that no securities are beneficially owned. This indicates the reporting person does not currently hold equity or derivative positions disclosed on Form 3. For corporate governance, such a disclosure is customary when an individual becomes a reporting person or assumes a director role.

TL;DR: Form 3 submitted identifying reporting person and issuer ticker, with no listed holdings.

The document identifies the issuer as Vyome Holdings, Inc. (ticker printed as HIND) and records the event date 08/15/2025. Table sections for non-derivative and derivative securities contain the statement: No securities are beneficially owned. The form is signed 09/18/2025, completing the initial filing requirements reflected in the document.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Tincoff John M. III

(Last) (First) (Middle)
HARVARD SQUARE,
ONE MIFFLIN PLACE, SUITE 400

(Street)
CAMBRIDGE MA 02138

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/15/2025
3. Issuer Name and Ticker or Trading Symbol
Vyome Holdings, Inc [ HIND ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ John Tincoff 09/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
ReShape Lifesciences Inc.

NASDAQ:RSLS

RSLS Rankings

RSLS Latest News

RSLS Latest SEC Filings

RSLS Stock Data

7.64M
5.48M
10.63%
1.35%
2.19%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN CLEMENTE